Skip to main content
Top
Published in: Japanese Journal of Radiology 6/2023

06-01-2023 | Mastectomy | Original Article

Global research trends in radiotherapy for breast cancer: a systematic bibliometric analysis

Authors: Beidi Jia, David Lim, Yisha Zhang, Chao Dong, Zhihui Feng

Published in: Japanese Journal of Radiology | Issue 6/2023

Login to get access

Abstract

Purpose

Breast cancer is the most common malignant tumor in women. Radiotherapy (RT) is an important adjunctive therapy for breast cancer, but the current international research trend of RT in breast cancer treatment and management is unclear. This bibliometric analysis was conducted to investigate the current trends and hot topics in this area.

Materials and methods

The Web of Science Core Collection (WoSCC; Clarivate) database was searched, VOSviewer 1.6.18 and CiteSpace 6.1.R2 software were employed for the quantitative and qualitative analysis.

Results

12,268 publications were included in this bibliometric analysis. There was an increasing trend of publications and international collaborations in the topic. The United States and The University of Texas MD Anderson Cancer Center were the most productive countries and institutions, respectively. The analysis of journals showed researches focused on both basic and clinical medicine on breast cancer RT. Park Won published the most papers and Fisher B had the most co-citations. The most co-cited paper was published in the Lancet. Survival, risk, chemotherapy, mastectomy, and surgery were regarded as current research hotspots through the analysis of keywords.

Conclusion

Through quantitative and qualitative bibliometric analyses, this study provides insights into the research trends and potential research hotspots on breast cancer RT.
Literature
1.
go back to reference Thompson JL, Wright GP. The role of breast MRI in newly diagnosed breast cancer: an evidence-based review. Am J Surg. 2021;221:525–8.PubMedCrossRef Thompson JL, Wright GP. The role of breast MRI in newly diagnosed breast cancer: an evidence-based review. Am J Surg. 2021;221:525–8.PubMedCrossRef
3.
go back to reference Weigelt B, Mackay A, A’Hern R, Natrajan R, Tan DS, Dowsett M, et al. Breast cancer molecular profiling with single sample predictors: a retrospective analysis. Lancet Oncol. 2010;11:339–49.PubMedCrossRef Weigelt B, Mackay A, A’Hern R, Natrajan R, Tan DS, Dowsett M, et al. Breast cancer molecular profiling with single sample predictors: a retrospective analysis. Lancet Oncol. 2010;11:339–49.PubMedCrossRef
4.
go back to reference Zhang YN, Xia KR, Li CY, Wei BL, Zhang B. Review of breast cancer pathologigcal image processing. Biomed Res Int. 2021;2021:1994764.PubMedPubMedCentral Zhang YN, Xia KR, Li CY, Wei BL, Zhang B. Review of breast cancer pathologigcal image processing. Biomed Res Int. 2021;2021:1994764.PubMedPubMedCentral
5.
go back to reference Ashwanikumar N, Plaut JS, Mostofian B, Patel S, Kwak P, Sun C, et al. Supramolecular self assembly of nanodrill-like structures for intracellular delivery. J Control Release. 2018;282:76–89.PubMedPubMedCentralCrossRef Ashwanikumar N, Plaut JS, Mostofian B, Patel S, Kwak P, Sun C, et al. Supramolecular self assembly of nanodrill-like structures for intracellular delivery. J Control Release. 2018;282:76–89.PubMedPubMedCentralCrossRef
6.
go back to reference McDonald ES, Clark AS, Tchou J, Zhang P, Freedman GM. Clinical diagnosis and management of breast cancer. J Nucl Med. 2016;57(Suppl 1):9S-16S.PubMedCrossRef McDonald ES, Clark AS, Tchou J, Zhang P, Freedman GM. Clinical diagnosis and management of breast cancer. J Nucl Med. 2016;57(Suppl 1):9S-16S.PubMedCrossRef
7.
go back to reference Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med. 2004;351:2817–26.PubMedCrossRef Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med. 2004;351:2817–26.PubMedCrossRef
8.
go back to reference Gradishar WJ, Anderson BO, Blair SL, Burstein HJ, Cyr A, Elias AD, et al. Breast cancer version 3.2014. J Natl Compr Canc Netw. 2014;12:542–90.PubMedCrossRef Gradishar WJ, Anderson BO, Blair SL, Burstein HJ, Cyr A, Elias AD, et al. Breast cancer version 3.2014. J Natl Compr Canc Netw. 2014;12:542–90.PubMedCrossRef
9.
go back to reference Correa C, McGale P, Taylor C, Wang Y, Clarke M, Davies C, et al. Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr. 2010;2010:162–77.PubMedCrossRef Correa C, McGale P, Taylor C, Wang Y, Clarke M, Davies C, et al. Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr. 2010;2010:162–77.PubMedCrossRef
10.
go back to reference Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378:1707–16.PubMedCrossRef Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378:1707–16.PubMedCrossRef
11.
go back to reference McCormick B, Winter K, Hudis C, Kuerer HM, Rakovitch E, Smith BL, et al. RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation. J Clin Oncol. 2015;33:709–15.PubMedPubMedCentralCrossRef McCormick B, Winter K, Hudis C, Kuerer HM, Rakovitch E, Smith BL, et al. RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation. J Clin Oncol. 2015;33:709–15.PubMedPubMedCentralCrossRef
12.
go back to reference Green MD, Brenneman R, Powell SN, Bergom C. Harnessing the DNA repair pathway in breast cancer: germline mutations/polymorphisms in breast radiation. Semin Radiat Oncol. 2022;32:298–302.PubMedCrossRef Green MD, Brenneman R, Powell SN, Bergom C. Harnessing the DNA repair pathway in breast cancer: germline mutations/polymorphisms in breast radiation. Semin Radiat Oncol. 2022;32:298–302.PubMedCrossRef
14.
go back to reference Verma S, Gustafsson A. Investigating the emerging COVID-19 research trends in the field of business and management: a bibliometric analysis approach. J Bus Res. 2020;118:253–61.PubMedPubMedCentralCrossRef Verma S, Gustafsson A. Investigating the emerging COVID-19 research trends in the field of business and management: a bibliometric analysis approach. J Bus Res. 2020;118:253–61.PubMedPubMedCentralCrossRef
15.
go back to reference Donthu N, Kumar S, Pandey N. A retrospective evaluation of marketing intelligence and planning: 1983–2019. Mark Intell Plan. 2021;39:48–73.CrossRef Donthu N, Kumar S, Pandey N. A retrospective evaluation of marketing intelligence and planning: 1983–2019. Mark Intell Plan. 2021;39:48–73.CrossRef
16.
go back to reference Donthu N, Kumar S, Pandey N, Lim WM. Research constituents, intellectual structure, and collaboration patterns in journal of international marketing: an analytical retrospective. J Int Mark. 2021;29:1–21.CrossRef Donthu N, Kumar S, Pandey N, Lim WM. Research constituents, intellectual structure, and collaboration patterns in journal of international marketing: an analytical retrospective. J Int Mark. 2021;29:1–21.CrossRef
17.
go back to reference Zhang Y, Lim D, Yao Y, Dong C, Feng Z. Global research trends in radiotherapy for gliomas: a systematic bibliometric analysis. World Neurosurg. 2022;161:e355–62.PubMedCrossRef Zhang Y, Lim D, Yao Y, Dong C, Feng Z. Global research trends in radiotherapy for gliomas: a systematic bibliometric analysis. World Neurosurg. 2022;161:e355–62.PubMedCrossRef
18.
go back to reference Das JP, Thulasidasan N, Ahmed I, Diamantopoulos A. Transarterial chemoembolization for hepatocellular carcinoma: a bibliometric analysis of the most cited articles. Jpn J Radiol. 2020;38:1190–6.PubMedCrossRef Das JP, Thulasidasan N, Ahmed I, Diamantopoulos A. Transarterial chemoembolization for hepatocellular carcinoma: a bibliometric analysis of the most cited articles. Jpn J Radiol. 2020;38:1190–6.PubMedCrossRef
19.
go back to reference Van Eck NJ, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics. 2010;84:523–38.PubMedCrossRef Van Eck NJ, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics. 2010;84:523–38.PubMedCrossRef
20.
go back to reference Mulet-Forteza C, Genovart-Balaguer J, Merigo JM, Mauleon-Mendez E. Bibliometric structure of IJCHM in its 30 years. Int J Contemp Hosp Manag. 2019;31:4574–604.CrossRef Mulet-Forteza C, Genovart-Balaguer J, Merigo JM, Mauleon-Mendez E. Bibliometric structure of IJCHM in its 30 years. Int J Contemp Hosp Manag. 2019;31:4574–604.CrossRef
21.
go back to reference Gao Y, Shi SZ, Ma WJ, Chen J, Cai YT, Ge L, et al. Bibliometric analysis of global research on PD-1 and PD-L1 in the field of cancer. Int Immunopharmacol. 2019;72:374–84.PubMedCrossRef Gao Y, Shi SZ, Ma WJ, Chen J, Cai YT, Ge L, et al. Bibliometric analysis of global research on PD-1 and PD-L1 in the field of cancer. Int Immunopharmacol. 2019;72:374–84.PubMedCrossRef
22.
go back to reference D’Arcangelo D, Giampietri C, Facchiano F, Facchiano A. BAMM: a preliminary bibliometric analysis on melanoma manuscripts. Pigment Cell Melanoma Res. 2013;26:415–7.PubMedCrossRef D’Arcangelo D, Giampietri C, Facchiano F, Facchiano A. BAMM: a preliminary bibliometric analysis on melanoma manuscripts. Pigment Cell Melanoma Res. 2013;26:415–7.PubMedCrossRef
23.
go back to reference Huang TJ, Wu HY, Yang SD, Su B, Tang K, Quan ZX, et al. Global trends of researches on sacral fracture surgery a bibliometric study based on VOSviewer. Spine. 2020;45:E721–8.PubMedCrossRef Huang TJ, Wu HY, Yang SD, Su B, Tang K, Quan ZX, et al. Global trends of researches on sacral fracture surgery a bibliometric study based on VOSviewer. Spine. 2020;45:E721–8.PubMedCrossRef
24.
go back to reference Abe O, Abe R, Enomoto K, Kikuchi K, Koyama H, Masuda H, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366:2087–106.CrossRef Abe O, Abe R, Enomoto K, Kikuchi K, Koyama H, Masuda H, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366:2087–106.CrossRef
25.
go back to reference Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–41.PubMedCrossRef Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–41.PubMedCrossRef
26.
go back to reference Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Bronnum D, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368:987–98.PubMedCrossRef Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Bronnum D, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368:987–98.PubMedCrossRef
27.
go back to reference McGale P, Taylor C, Correa C, Cutter D, Duane F, Ewertz M, et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet. 2014;383:2127–35.PubMedCrossRef McGale P, Taylor C, Correa C, Cutter D, Duane F, Ewertz M, et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet. 2014;383:2127–35.PubMedCrossRef
28.
go back to reference Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227–32.PubMedCrossRef Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227–32.PubMedCrossRef
29.
go back to reference Whelan TJ, Pignol JP, Levine MN, Julian JA, MacKenzie R, Parpia S, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010;362:513–20.PubMedCrossRef Whelan TJ, Pignol JP, Levine MN, Julian JA, MacKenzie R, Parpia S, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010;362:513–20.PubMedCrossRef
30.
go back to reference Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med. 1997;337:949–55.PubMedCrossRef Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med. 1997;337:949–55.PubMedCrossRef
31.
go back to reference Bentzen SM, Agrawal RK, Aird EG, Barrett JM, Barrett-Lee PJ, Bentzen SM, et al. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet. 2008;371:1098–107.PubMedCrossRef Bentzen SM, Agrawal RK, Aird EG, Barrett JM, Barrett-Lee PJ, Bentzen SM, et al. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet. 2008;371:1098–107.PubMedCrossRef
32.
go back to reference Haviland JS, Owen JR, Dewar JA, Agrawal RK, Barrett J, Barrett-Lee PJ, et al. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol. 2013;14:1086–94.PubMedCrossRef Haviland JS, Owen JR, Dewar JA, Agrawal RK, Barrett J, Barrett-Lee PJ, et al. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol. 2013;14:1086–94.PubMedCrossRef
33.
go back to reference Poortmans PM, Collette S, Kirkove C, Van Limbergen E, Budach V, Struikmans H, et al. Internal mammary and medial supraclavicular irradiation in breast cancer. N Engl J Med. 2015;373:317–27.PubMedCrossRef Poortmans PM, Collette S, Kirkove C, Van Limbergen E, Budach V, Struikmans H, et al. Internal mammary and medial supraclavicular irradiation in breast cancer. N Engl J Med. 2015;373:317–27.PubMedCrossRef
34.
go back to reference Mc WR. The principles of treatment by radiotherapy in breast carcinoma. Br J Cancer. 1950;4:368–71.CrossRef Mc WR. The principles of treatment by radiotherapy in breast carcinoma. Br J Cancer. 1950;4:368–71.CrossRef
35.
go back to reference Miglietta F, Griguolo G, Guarneri V, Dieci MV. Programmed cell death ligand 1 in breast cancer: technical aspects, prognostic implications, and predictive value. Oncologist. 2019;24:E1055–69.PubMedPubMedCentralCrossRef Miglietta F, Griguolo G, Guarneri V, Dieci MV. Programmed cell death ligand 1 in breast cancer: technical aspects, prognostic implications, and predictive value. Oncologist. 2019;24:E1055–69.PubMedPubMedCentralCrossRef
37.
go back to reference Kodonas K, Fardi A, Gogos C, Economides N. Scientometric analysis of vital pulp therapy studies. Int Endod J. 2021;54:220–30.PubMedCrossRef Kodonas K, Fardi A, Gogos C, Economides N. Scientometric analysis of vital pulp therapy studies. Int Endod J. 2021;54:220–30.PubMedCrossRef
38.
go back to reference DeSantis C, Siegel R, Bandi P, Jemal A. Breast cancer statistics, 2011. CA Cancer J Clin. 2011;61:409–18.PubMedCrossRef DeSantis C, Siegel R, Bandi P, Jemal A. Breast cancer statistics, 2011. CA Cancer J Clin. 2011;61:409–18.PubMedCrossRef
39.
go back to reference Anastasiadi Z, Lianos GD, Ignatiadou E, Harissis HV, Mitsis M. Breast cancer in young women: an overview. Updates Surg. 2017;69:313–7.PubMedCrossRef Anastasiadi Z, Lianos GD, Ignatiadou E, Harissis HV, Mitsis M. Breast cancer in young women: an overview. Updates Surg. 2017;69:313–7.PubMedCrossRef
40.
go back to reference He MY, Rancoule C, Rehailia-Blanchard A, Espenel S, Trone JC, Bernichon E, et al. Radiotherapy in triple-negative breast cancer: current situation and upcoming strategies. Crit Rev Oncol Hematol. 2018;131:96–101.PubMedCrossRef He MY, Rancoule C, Rehailia-Blanchard A, Espenel S, Trone JC, Bernichon E, et al. Radiotherapy in triple-negative breast cancer: current situation and upcoming strategies. Crit Rev Oncol Hematol. 2018;131:96–101.PubMedCrossRef
41.
go back to reference Ning WJ, Liu X, Zeng HY, An ZQ, Luo WX, Xia NS. Recent progress in antibody-based therapeutics for triple-negative breast cancer. Expert Opin Drug Deliv. 2022;19:815–32.PubMedCrossRef Ning WJ, Liu X, Zeng HY, An ZQ, Luo WX, Xia NS. Recent progress in antibody-based therapeutics for triple-negative breast cancer. Expert Opin Drug Deliv. 2022;19:815–32.PubMedCrossRef
43.
go back to reference Bennion NR, Baine M, Granatowicz A, Wahl AO. Accelerated partial breast radiotherapy: a review of the literature and future directions. Gland Surg. 2018;7:596–610.PubMedPubMedCentralCrossRef Bennion NR, Baine M, Granatowicz A, Wahl AO. Accelerated partial breast radiotherapy: a review of the literature and future directions. Gland Surg. 2018;7:596–610.PubMedPubMedCentralCrossRef
44.
go back to reference Orecchia R, Veronesi U, Maisonneuve P, Galimberti VE, Lazzari R, Veronesi P, et al. Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomised, phase 3 equivalence trial. Lancet Oncol. 2021;22:597–608.PubMedCrossRef Orecchia R, Veronesi U, Maisonneuve P, Galimberti VE, Lazzari R, Veronesi P, et al. Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomised, phase 3 equivalence trial. Lancet Oncol. 2021;22:597–608.PubMedCrossRef
45.
go back to reference Grossberg AJ, Lei X, Xu T, Shaitelman SF, Hoffman KE, Bloom ES, et al. Association of transforming growth factor beta polymorphism C-509T with radiation-induced fibrosis among patients with early-stage breast cancer: a secondary analysis of a randomized clinical trial. JAMA Oncol. 2018;4:1751–7.PubMedPubMedCentralCrossRef Grossberg AJ, Lei X, Xu T, Shaitelman SF, Hoffman KE, Bloom ES, et al. Association of transforming growth factor beta polymorphism C-509T with radiation-induced fibrosis among patients with early-stage breast cancer: a secondary analysis of a randomized clinical trial. JAMA Oncol. 2018;4:1751–7.PubMedPubMedCentralCrossRef
46.
go back to reference Woo J, Moon BI, Kwon H, Lim W. Effect of radiotherapy sequence on long-term outcome in patients with node-positive breast cancer: a retrospective study. Sci Rep. 2022;12:10729.PubMedPubMedCentralCrossRef Woo J, Moon BI, Kwon H, Lim W. Effect of radiotherapy sequence on long-term outcome in patients with node-positive breast cancer: a retrospective study. Sci Rep. 2022;12:10729.PubMedPubMedCentralCrossRef
47.
go back to reference Cao L, Xu C, Cai G, Qi WX, Cai R, Wang SB, et al. How does the interval between completion of adjuvant chemotherapy and initiation of radiotherapy impact clinical outcomes in operable breast cancer patients? Ann Surg Oncol. 2021;28:2155–68.PubMedCrossRef Cao L, Xu C, Cai G, Qi WX, Cai R, Wang SB, et al. How does the interval between completion of adjuvant chemotherapy and initiation of radiotherapy impact clinical outcomes in operable breast cancer patients? Ann Surg Oncol. 2021;28:2155–68.PubMedCrossRef
48.
go back to reference Woodward SG, Varshney K, Anne PR, George BJ, Willis AI. Trends in use of hypofractionated whole breast radiation in breast cancer: an analysis of the national cancer database. Int J Radiat Oncol Biol Phys. 2021;109:449–57.PubMedCrossRef Woodward SG, Varshney K, Anne PR, George BJ, Willis AI. Trends in use of hypofractionated whole breast radiation in breast cancer: an analysis of the national cancer database. Int J Radiat Oncol Biol Phys. 2021;109:449–57.PubMedCrossRef
49.
go back to reference Smith BD, Bellon JR, Blitzblau R, Freedman G, Haffty B, Hahn C, et al. Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline. Pract Radiat Oncol. 2018;8:145–52.PubMedCrossRef Smith BD, Bellon JR, Blitzblau R, Freedman G, Haffty B, Hahn C, et al. Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline. Pract Radiat Oncol. 2018;8:145–52.PubMedCrossRef
Metadata
Title
Global research trends in radiotherapy for breast cancer: a systematic bibliometric analysis
Authors
Beidi Jia
David Lim
Yisha Zhang
Chao Dong
Zhihui Feng
Publication date
06-01-2023
Publisher
Springer Nature Singapore
Published in
Japanese Journal of Radiology / Issue 6/2023
Print ISSN: 1867-1071
Electronic ISSN: 1867-108X
DOI
https://doi.org/10.1007/s11604-022-01383-x

Other articles of this Issue 6/2023

Japanese Journal of Radiology 6/2023 Go to the issue

Letter to the Editor

Letter to the Editor